Delivery Order V797D70102-36C26024F0173
Award Date
1/1/24
Potential Completion Date
12/31/24
Potential Value
$154K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Vanda Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HETLIOZ (tasimelteon), a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to the prime contractor, Vanda Pharmaceuticals Inc., doing business as Vanda, on October 1, 2024. The contract has a ceiling value of $162,771.05 and a performance period extending through September 30, 2025. This award is a delivery order placed against Vanda's existing GSA Federal Supply Schedule contract for...
This federal contract award from the Department of Veterans Affairs (VA) to Vanda Pharmaceuticals Inc. (Vanda) is for the delivery of the medication Hetlioz (tasimelteon) to the VA's Veterans Integrated Service Network 16. The $128,543.49 delivery order contract is a firm fixed-price instrument placed against Vanda's Pharmaceuticals and Drugs GSA Schedule contract. Hetlioz is used to treat Non-24-Hour Sleep-Wake Disorder, a condition affecting many veterans. This award is not designated as a...
The Department of Veterans Affairs (VA) awarded a $77,798.53 delivery order contract to Vanda Pharmaceuticals Inc. (Vanda) for the provision of HETLIOZ 20MG CAPSULE. This contract is issued against Vanda's Pharmaceuticals and Drugs GSA Schedule contract and has no set-aside designation. Vanda, a global biopharmaceutical company, is the manufacturer of HETLIOZ, a medication used to treat Non-24-Hour Sleep-Wake Disorder in patients served by the VA. This delivery order has a completion date of...
This is a firm fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The award is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract has a ceiling value of...
This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The $10,170 firm-fixed-price delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued against Harmony Biosciences' General Services...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract, valued at $20,340, is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was placed against Harmony Biosciences' General...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The award was for the delivery of WAKIX 17.8 mg tablets, a drug used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is a Firm Fixed Price Delivery Order under Harmony Biosciences' Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals...
This is a federal contract award from the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company that specializes in medications for rare neurological diseases and sleep disorders. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, with a ceiling value of $10,418.14. The contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, for the supply of WAKIX (pitolisant) 17.8 mg tablets. The contract has a ceiling value of $5,209.20 and a performance period ending on February 14, 2025. The order was placed against Harmony Biosciences' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This indicates that Harmony Biosciences has a broader,...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract, valued at $5,085.00, is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients....